Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study
Biomolecules · 2023
DOI: 10.3390/biom13071094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Aida Kamalian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institutes of Aging.
Abstract (Originalsprache)
(1)
Background
Despite the existence of well-established, CSF-based biomarkers such as amyloid-β and phosphorylated-tau, the pathways involved in the pathophysiology of Alzheimer’s disease (AD) remain an active area of research. (2)
Methods
We measured 3072 proteins in CSF samples of AD-biomarker positive mild cognitive impairment (MCI) participants (n = 38) and controls (n = 48), using the Explore panel of the Olink proximity extension assay (PEA). We performed group comparisons, association studies with diagnosis, age, and APOE ε4 status, overrepresentation analysis (ORA), and gene set enrichment analysis (GSEA) to determine differentially expressed proteins and dysregulated pathways. (3)
Results
GSEA results demonstrated an enrichment of granulocyte-related and chemotactic pathways (core enrichment proteins: ITGB2, ITGAM, ICAM1, SELL, SELP, C5, IL1A). Moreover, some of the well-replicated, differentially expressed proteins in CSF included: ITGAM, ITGB2, C1QA, TREM2, GFAP, NEFL, MMP-10, and a novel tau-related marker, SCRN1. (4)
Conclusion
Our results highlight the upregulation of neuroinflammatory pathways, especially chemotactic and granulocyte recruitment in CSF of early AD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Department of Neurology, Duke University School of Medicine, Durham, NC 27710, USA.
ORCID-Profile: Aida Kamalian, Alexandria Lewis, Abhay Moghekar, Michael W Lutz
Förderung
- NIA NIH HHS
- National Institutes of Aging
Zitieren
APA
Kamalian, A., Ho, S. G., Patel, M., Lewis, A., Bakker, A., Albert, M., O'Brien, R. J., Moghekar, A., & Lutz, M. W. (2023). Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study. Biomolecules. https://doi.org/10.3390/biom13071094
Vancouver
Kamalian A, Ho SG, Patel M, Lewis A, Bakker A, Albert M, et al. Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study. Biomolecules. 2023. doi:10.3390/biom13071094
BibTeX
@article{Kamalian2023,
author = {Kamalian, Aida and Ho, Sara G and Patel, Megha and Lewis, Alexandria and Bakker, Arnold and Albert, Marilyn and O'Brien, Richard J and Moghekar, Abhay and Lutz, Michael W},
title = {Exploratory Assessment of Proteomic Network Changes in Cerebrospinal Fluid of Mild Cognitive Impairment Patients: A Pilot Study},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13071094}
}
EUVIMED